TUMBARELLO, MARIO
 Distribuzione geografica
Continente #
EU - Europa 256
NA - Nord America 84
AS - Asia 25
AF - Africa 1
Totale 366
Nazione #
IT - Italia 95
US - Stati Uniti d'America 83
IE - Irlanda 57
DE - Germania 20
ES - Italia 20
UA - Ucraina 14
NL - Olanda 13
CN - Cina 9
FR - Francia 9
CZ - Repubblica Ceca 6
FI - Finlandia 6
GB - Regno Unito 5
IN - India 4
SE - Svezia 4
SA - Arabia Saudita 3
JP - Giappone 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CA - Canada 1
CH - Svizzera 1
IL - Israele 1
MA - Marocco 1
MY - Malesia 1
PH - Filippine 1
PL - Polonia 1
SG - Singapore 1
SI - Slovenia 1
TR - Turchia 1
Totale 366
Città #
Dublin 53
Siena 23
Florence 21
Seville 19
Ashburn 18
Columbus 14
Shanghai 7
Amsterdam 6
Brescia 6
Lappeenranta 6
Milan 6
Arezzo 4
Buffalo 4
Chicago 4
Stockholm 4
Fairfield 3
Los Angeles 3
Makkah 3
Southend 3
Casciana Terme 2
Council Bluffs 2
Herndon 2
London 2
Monte San Savino 2
Mumbai 2
New York 2
Nuremberg 2
Orléans 2
Seattle 2
Aubervilliers 1
Bergamo 1
Boardman 1
Bologna 1
Buggiano 1
Bussero 1
Cagliari 1
Cedar Knolls 1
Collegeville 1
Crugers 1
Dallas 1
Detmold 1
Edison 1
Edmonton 1
Frankfurt am Main 1
Gdynia 1
Hachenburg 1
Henderson 1
Indore 1
Kayseri 1
Kobe 1
Kuala Lumpur 1
Las Vegas 1
Milpitas 1
Naples 1
Oradea 1
Osimo 1
Padova 1
Paris 1
Pavia 1
Pescara 1
Pisa 1
Poggio a Caiano 1
Portland 1
Providence 1
Pune 1
Quezon City 1
Rabat 1
Rho 1
Rochester 1
Rome 1
Saint-Brieuc 1
Salem 1
San Diego 1
Santa Maria a Monte 1
Sunnyvale 1
Tampa 1
Tappahannock 1
Tel Aviv 1
Târgu Mureş 1
Umeda 1
Valencia 1
Yerevan 1
Zurich 1
Totale 281
Nome #
null, file e0feeaaa-52ef-44d2-e053-6605fe0a8db0 63
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males., file e8887f01-8ecd-408c-a6e4-5b1d8e6d5c42 42
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19, file 96f4df86-86ac-462c-8a12-3ca958289b45 31
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV, file 8813b76e-2fb3-4533-b729-93d6aa903340 25
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort), file 32ea4e22-5767-4131-a89d-34492dac165f 24
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia, file e0feeaaa-dee1-44d2-e053-6605fe0a8db0 24
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients, file e0feeaab-0e66-44d2-e053-6605fe0a8db0 21
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine), file e0feeaab-9d9a-44d2-e053-6605fe0a8db0 16
Mapping the human genetic architecture of COVID-19, file e0feeaab-73d3-44d2-e053-6605fe0a8db0 15
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age, file 530676af-72b7-4a15-b48a-51204a80e40d 13
Whole-genome sequencing reveals host factors underlying critical COVID-19, file b47ac884-9c8d-4cf9-84ab-2c6dfbaa52e5 13
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes, file ebc57d5c-8d48-406c-b361-06dd583c7b6b 13
An explainable model of host genetic interactions linked to COVID-19 severity, file a40b8f9e-8132-42fb-ba8e-085aaa454eda 12
null, file 385893c5-b7c4-4d3e-a732-6db17b23ee3f 10
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine, file d868aa3a-943e-461f-84cd-1ada9ae596f8 9
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper, file e0feeaab-40af-44d2-e053-6605fe0a8db0 8
An Observational Study to Develop a Predictive Model for Bacterial Pneumonia Diagnosis in Severe COVID-19 Patients—C19-PNEUMOSCORE, file f296eb3e-944d-4071-8d3c-97f406f8c9e1 7
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants, file e0feeaab-40b7-44d2-e053-6605fe0a8db0 4
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study., file e0feeaab-e218-44d2-e053-6605fe0a8db0 4
Pathogen-sugar interactions revealed by universal saturation transfer analysis, file 83e3ea53-7dd8-465d-985b-a21f380e98c4 2
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?, file d78a550b-0c6c-45ab-9b29-e8566e1ec8a9 2
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation, file e0feeaaa-ef9e-44d2-e053-6605fe0a8db0 2
Use of colistin in adult patients: A cross-sectional study, file e0feeaab-03b2-44d2-e053-6605fe0a8db0 2
A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement, file e0feeaab-122a-44d2-e053-6605fe0a8db0 2
Ceftolozane/tazobactam for treatment of severe ESBL-producing enterobacterales infections: A multicenter nationwide clinical experience (CEFTABUSE II Study), file e0feeaab-2f32-44d2-e053-6605fe0a8db0 2
Evaluation of the New NucliSENS EasyQ KPC Test for Rapid Detection of Klebsiella pneumoniae Carbapenemase Gene (blaKPC)., file e0feeaa5-fcb7-44d2-e053-6605fe0a8db0 1
Totale 367
Categoria #
all - tutte 2.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 1 0
2021/202236 6 2 0 0 0 2 8 1 5 3 6 3
2022/2023131 1 0 4 32 16 18 15 11 7 9 9 9
2023/2024199 8 19 10 17 8 33 42 9 4 29 20 0
Totale 367